MitoQ

Start-up Sentai wins UK independent living grant

Latest articles

Drive to end cancer could pioneer diagnostic technology

Blood test that can determine a cancer signal origin with high accuracy is now available on prescription in the US and could lead to...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...

New SIRT6 activator supplement hits the market

Sirtuin 6, the protein making waves in the longevity pool, can now be activated by a brand-new supplement. SIRT6 is a protein with an important...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
fundraising

Editor's picks

Drive to end cancer could pioneer diagnostic technology

Blood test that can determine a cancer signal origin with high accuracy is now available on prescription in the US and could lead to...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...
MitoQ

Click the globe for translations.

Machine-learning smart device uses AI to promote independence and safety.

A British technology start-up focused on helping the elderly live more independently in their own home has received financial backing from the UK Government. Accelerated by the coronavirus crisis and rising loneliness amongst the elderly, Sentai, a portable smart device using AI and Augmented Voice Technology to monitor and support older people, has received a grant from Innovate UK, the UK’s innovation agency.

Longevity.Technology:  This device concept hits the market at a time when it is estimated 1.4 million people aged 50 and over in England alone suffer from loneliness. And with the number of people in Europe aged 80 and over expected to more than double by 2070, from 29 million to over 60 million, the need to support and monitor the elderly will be crucial in a post-pandemic world.

Thanks to advancements in machine-learning capabilities, Sentai can provide a contextual experience with the user, meaning conversations feel natural rather than robotic or one way. For example, it can detect the mood of a person from their voice and centre responses around that, whilst providing timely prompts around important things such as medication.

The idea is to offer a small, discreet, personal task force to deal with the day-to-day care needs of the elderly, whilst keeping them connected to their loved ones and community. The caregiver can stay connected via a smart app, with daily performance logs and push notifications enabling them to get peace of mind.

Phil Marshman, Sentai’s CEO and founder, said: “We’re delighted to see the Government backing us under the Sustainable Innovation Fund, as it serves to underline how much our product is needed. With winter fast approaching and another national lockdown underway, loneliness is only set to rise further, and we want to be able to ensure our loved ones are monitored and supported when we can’t physically be with them.”

 


 

“We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

 


 

He continued: “We’re now one step closer to making Sentai accessible to all who need it and incredibly excited at the prospect of being able to offer a viable solution to combatting loneliness, thereby improving quality of life and ensuring peace of mind.”

Also, equipped with sensors, Sentai monitors movements and can call for help if someone falls, and can remind them to take medication throughout the day as needed.

Dr Ian Campbell, Executive Chair of Innovate UK, said: “In these difficult times we have seen the best of British business innovation. The pandemic is not just a health emergency but one that impacts society and the economy.

“Sentai, along with every initiative Innovate UK has supported through this fund, is an important step forward in driving sustainable economic development. Each one is also helping to realise the ambitions of hard-working people.”

Innovate UK is investing up to £191million to fund research and development projects with the aim of helping all sectors of the UK rebuild after the effects of COVID-19, the fund is supporting 1,103 projects and 1,189 UK businesses, totalling over £130million in aid.

We recently reported how the UK’s Industrial Strategy Challenge Fund has developed a programme to promote new healthy aging solutions. The Healthy Aging Investment Accelerator is a five-year initiative to support smaller tech companies who are working to combat health issues related to the aging process, and is part of the UK Government’s commitment to developing the role technology can play in improving healthcare.

To further help get the device into the homes of people who need it, Sentai is preparing to launch a Kickstarter campaign to raise funds for the next stage of its development – the success of which will see its pioneering technology brought to mass market. Details of the Kickstarter are due to be announced imminently.

Image courtesy of Sentai
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
MitoQ

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
fundraising

Related articles

Occuity – shining a light on health and longevity

Forget windows to the soul, Occuity's non-invasive smart diagnostic tech provides a window to health and wellness. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited)...

Workforce wellbeing platform scales up

Digital twin platform syd gets deployed by NHS, closes first workplace wellbeing deal in US and kicks off independent studies. DISCLOSURE: Longevity.Technology (a brand...

PCL Health embarks on preventive care trial with NHS

PCL Health enables preventive care by driving actionable insights from a wide range of health data. DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has...

Wyss Center gets CE mark for NeuroKey brain-AI interface

The Wyss Center announces CE mark for its brain-computer interface software for communication, NeuroKey BCI, which enables communication in real time. The Wyss Center, which...

Building a virtual model to solve human aging

Peter Fedichev explains how Gero is using AI and activity data to accelerate our understanding of human aging. We recently reported on AI firm Gero’s...
Supps report ad middle